Zuellig Pharma Acquires Hangzhou Facility to Expand Chinese Clinical Sourcing
November 05, 2026 | 15:16
Healthcare distribution firm Zuellig Pharma acquired a licensed facility in Hangzhou to establish local clinical trial supply and sourcing capabilities across mainland China.
Mobile Version